News New US health secretary Azar will tackle drug prices, say Tr... President Trump has sworn in ex-pharma industry executive Alex Azar as his new Health Secretary – and says tackling drug prices and the opioid crisis will be among his top priorities.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.